Log in to add personal notes on this page.
Cells make cholesterol through a long series of steps, the last of which turns 7-dehydrocholesterol into cholesterol, and the liver turns part of it into bile acids. In the blood, cholesterol rides in lipoproteins: LDL is cleared into liver cells by the LDL receptor, and HDL is built when cells export cholesterol onto apolipoprotein A-I. Free cholesterol released inside the cell then tells it to make less and take up less, so a block can raise cholesterol, lower it, divert it, or strand it inside cells.
- 7-dehydrocholesterol → cholesterol: 7-dehydrocholesterol reductase (DHCR7), the last step of synthesis. Blocked in Smith-Lemli-Opitz syndrome.
- cholesterol → chenodeoxycholic acid and the other primary bile acids: sterol 27-hydroxylase (CYP27A1), a mitochondrial enzyme in the liver. Blocked in cerebrotendinous xanthomatosis.
- LDL in blood → bound and taken into liver cells: the LDL receptor (LDLR) binds apolipoprotein B-100 (APOB); an adapter protein (LDLRAP1) carries receptor and particle inside; the PCSK9 protein (PCSK9) sends receptors to be degraded. Blocked in familial hypercholesterolemia.
- cholesteryl esters and triglycerides in the lysosome → free cholesterol: lysosomal acid lipase (LIPA). Blocked in lysosomal acid lipase deficiency (Wolman disease).
- free cholesterol reaches the endoplasmic reticulum → HMG-CoA reductase activity (synthesis) and LDL receptor gene transcription are turned down.
- cholesterol and phospholipid inside cells → loaded onto apoA-I → nascent HDL: the membrane lipid flippase (ABCA1). Blocked in Tangier disease.
- Smith-Lemli-Opitz syndrome: 7-dehydrocholesterol and 8-dehydrocholesterol build up and cholesterol is generally low. The result is multiple congenital anomalies, with 2-3 toe syndactyly in nearly all, although how the sterol changes cause the malformations is not known.
- Cerebrotendinous xanthomatosis: with bile acid synthesis blocked, cholesterol is diverted to cholestanol, which deposits in tendons and brain. Chenodeoxycholic acid is low and bile alcohols rise in urine and plasma; too little bile acid explains the chronic diarrhea, and juvenile cataracts are common. Replacing chenodeoxycholic acid normalizes cholestanol.
- Familial hypercholesterolemia: less LDL is cleared from blood, so LDL cholesterol stays high and lays down coronary plaque early; two pathogenic alleles can push it above 500 mg/dL. LDLR and APOB variants are loss of function, PCSK9 variants gain of function (too many receptors degraded), and LDLRAP1 is the rare recessive form.
- Lysosomal acid lipase deficiency: cholesteryl esters and triglycerides are trapped in lysosomes, enlarging the liver and spleen. Too little free cholesterol reaches its sensor, so synthesis and LDL uptake stay switched on. Infantile onset (Wolman) has activity absent or 1% or less and adrenal calcification in up to 74%; later onset keeps 2% to 11%.
- Tangier disease: cholesterol and phospholipid cannot be loaded onto apoA-I, so the lipid-poor apoA-I is degraded and HDL cholesterol falls below about 5 mg/dL. Cholesteryl esters build up in tissues, most of all in reticuloendothelial cells, giving yellow-orange tonsils and an enlarged liver and spleen; peripheral neuropathy is the other major sign.
- High LDL cholesterol points to familial hypercholesterolemia, but lysosomal acid lipase deficiency gives the same high LDL with low HDL and high triglycerides; the enzyme assay in leukocytes or dried blood spots separates them.
- HDL near zero with a low LDL is Tangier disease.
- Xanthomas with a normal or low cholesterol point to cerebrotendinous xanthomatosis; the marker is a high plasma cholestanol.
- Congenital anomalies with low cholesterol point to Smith-Lemli-Opitz syndrome; order a specific 7-dehydrocholesterol level, because the routine assay counts the precursors as cholesterol and can read normal.
WOLMAN: WithOut Lipase, Mineralized Adrenals in the Newborn, for the adrenal calcification of infantile lysosomal acid lipase deficiency.